PHARMACEUTICAL PREPARATIONS SKIN WOUNDS

Brand Owner (click to sort) Address Description
COLLANEX Stratus Pharmaceuticals, Inc. 145 SE 25th Rd Ste.1102 12379 SW 130 St Miami FL 33186 Pharmaceutical preparations for skin wounds, namely, wound care powders, gels, and liquids;
OMEGA3 VIRUXIDE KERECIS HF Eyrargata 2 Isafjordur 400 Iceland Pharmaceutical preparations for skin wounds; Antimicrobial preparations for preventing infectious disease in humans; Pharmaceutical products for the prevention or treatment of microbial diseases in humans; Antimicrobial preparations for treating or alleviating symptomatic infections in humans; Cold and flu symptom treatment preparations; Antimicrobial preparations containing plant extracts and fish oils; Antimicrobial preparations containing neem oil, Hypericum extracts, and fish-derived polyunsaturated fatty acids;
PRIME ProMend Animal Health Inc 3011 Centre Oak Way, Ste 102 Germantown TN 38139 Pharmaceutical preparations for skin wounds for veterinary purposes; Pharmaceutical preparations for veterinary wound care; Wound dressings for veterinary purposes;
VIRUXAL KERECIS AG Webereistrasse 61 Adliswil 8134 Switzerland Pharmaceutical preparations for skin wounds; Antimicrobial preparations for preventing infectious disease in humans; Pharmaceutical products for the prevention or treatment of microbial diseases in humans; Antimicrobial preparations for treating or alleviating symptomatic infections in humans; Cold and flu symptom treatment preparations; Antimicrobial preparations containing plant extracts and fish oils for the prevention or treatment of microbial diseases or symptomatic infections in humans; Antimicrobial preparations containing neem oil, Hypericum extracts, and fish-derived polyunsaturated fatty acids for the prevention or treatment of microbial diseases or symptomatic infections in humans;
VIRUXIDE KERECIS HF Eyrargata 2 Isafjordur 400 Iceland Pharmaceutical preparations for skin wounds; Antimicrobial preparations for preventing infectious disease in humans; Pharmaceutical products for the prevention or treatment of microbial diseases in humans; Antimicrobial preparations for treating or alleviating symptomatic infections in humans; Cold and flu symptom treatment preparations; Antimicrobial preparations containing plant extracts and fish oils; Antimicrobial preparations containing neem oil, Hypericum extracts, and fish-derived polyunsaturated fatty acids;
VIRUXNASAL KERECIS AG Webereistrasse 61 Adliswil 8134 Switzerland Pharmaceutical preparations for skin wounds; Antimicrobial preparations for preventing infectious disease in humans; Pharmaceutical products for the prevention and treatment of microbial diseases in humans; Antimicrobial preparations for treating and alleviating symptomatic infections in humans; Cold and flu symptom treatment preparations; Antimicrobial preparations containing plant extracts and fish oils for preventing viruses; Antimicrobial preparations containing neem oil, Hypericum extracts, and fish-derived polyunsaturated fatty acids for preventing viruses;
VIRUXORAL KERECIS AG Webereistrasse 61 Adliswil 8134 Switzerland Pharmaceutical preparations for skin wounds; Antimicrobial preparations for preventing infectious disease in humans; Pharmaceutical products for the prevention and treatment of microbial diseases in humans; Antimicrobial preparations for treating and alleviating symptomatic infections in humans; Cold and flu symptom treatment preparations; Antimicrobial preparations containing plant extracts and fish oils for preventing viruses; Antimicrobial preparations containing neem oil, Hypericum extracts, and fish-derived polyunsaturated fatty acids for preventing viruses;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A device and method is disclosed for the treatment of early stage wounds, i.e. those wounds that have resulted in little or no breach of the skin tissue. The invention utilizes non-ablative laser or non-coherent electromagnetic radiation applied to a stage one or two wound to stimulate wound healing, destroy viral and bacterial bodies, and prevent the development of such wounds into higher stage wounds. An appropriate wavelength is chosen from the range of 193 nm to 10.6 microns, and is delivered at a power density of about at least 1 W/cm